Literature DB >> 6983298

A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

J R Beck, S G Pauker, J E Gottlieb, K Klein, J P Kassirer.   

Abstract

We show how to use a bedside approximation of life expectancy in quantitative decision-making. This method, the declining exponential approximation of life expectancy (DEALE), enables the physician to collate various survival data with information on morbidity to determine a quality-adjusted expected survival for a potential management plan. The keystone in the DEALE approach is the approximation of survival by a simple exponential function. This approximation makes it possible to translate data from various literature sources (life expectancy tables, five-year survival rates, survival curves, median survival) into a single, unified mortality scale. In this paper, we use the DEALE method to obtain approximations of quality-adjusted life expectancy and illustrate the application of the method in a quantitative analysis of a clinical decision.

Mesh:

Year:  1982        PMID: 6983298     DOI: 10.1016/0002-9343(82)90787-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  83 in total

1.  Bridging decision analytic modelling with a cross-sectional study. Application to Parkinson's disease.

Authors:  M J Nuijten
Journal:  Pharmacoeconomics       Date:  2000-03       Impact factor: 4.981

2.  Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

Authors:  Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur
Journal:  Radiology       Date:  2014-11-12       Impact factor: 11.105

3.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

4.  Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit.

Authors:  Colleen L Jay; Anton I Skaro; Daniela P Ladner; Edward Wang; Vadim Lyuksemburg; Yaojen Chang; Hongmei Xu; Sandhya Talakokkla; Neehar Parikh; Jane L Holl; Gordon B Hazen; Michael M Abecassis
Journal:  Liver Transpl       Date:  2012-06       Impact factor: 5.799

5.  Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus.

Authors:  Patrick Yachimski; Sachin Wani; Tonya Givens; Eric Howard; Tina Higginbotham; Angie Price; Kenneth Berman; Lindsay Hosford; Paul Menard Katcher; Elissa Ozanne; Katherine Perzan; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-26       Impact factor: 11.382

6.  Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.

Authors:  Yasuaki Hayashino; Sizuko Nagata-Kobayashi; Takeshi Morimoto; Kenji Maeda; Takuro Shimbo; Tsuguya Fukui
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

7.  Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors.

Authors:  Virginie Nerich; Camille Fleck; Loïc Chaigneau; Nicolas Isambert; Christophe Borg; Elsa Kalbacher; Marine Jary; Pauline Simon; Xavier Pivot; Jean-Yves Blay; Samuel Limat
Journal:  Clin Drug Investig       Date:  2017-01       Impact factor: 2.859

8.  Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

Authors:  Scott K Sherman; Joel J Lange; Fadi S Dahdaleh; Rahul Rajeev; T Clark Gamblin; Blase N Polite; Kiran K Turaga
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

9.  Validation of a decision model for preventive pharmacological strategies in postmenopausal women.

Authors:  Sylvie Perreault; Carey Levinton; Claudine Laurier; Yola Moride; Louis-Georges Ste-Marie; Ralph Crott
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

10.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.